FDA Forced To Review Cholesterol Drug Exclusivity
Departing from a lower court ruling, the U.S. Court of Appeals for the District of Columbia Circuit has demanded that the U.S. Food and Drug Administration revisit the issue of generic...To view the full article, register now.
Already a subscriber? Click here to view full article